Benefits of modifying the predictive factors of stroke recurrence

Cerebrovascular Diseases

Volumn 20, Issue SUPPL. 2, 2005, Pages 84-90

  Egido Herrero, José A ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Risk factors; Secondary prevention; Stroke recurrence

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; HOMOCYSTEINE; TICLOPIDINE;

ATHEROSCLEROTIC PLAQUE; BRAIN INFARCTION; CAROTID ARTERY OBSTRUCTION; CONFERENCE PAPER; DEMENTIA; DIABETES MELLITUS; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEMOSTASIS; HUMAN; HYPERTENSION; INFLAMMATION; LEUKOARAIOSIS; MEDICAL RESEARCH; MICROEMBOLISM; NEUROIMAGING; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SILENT MYOCARDIAL INFARCTION; STROKE; THROMBOSIS; ULCER; AGE; AGED; BLOOD; CEREBROVASCULAR ACCIDENT; PATHOLOGY; PHYSIOLOGY; REVIEW;

AGE FACTORS; AGED; BIOLOGICAL MARKERS; CEREBROVASCULAR ACCIDENT; DEMENTIA; HEMOSTASIS; HOMOCYSTEINE; HUMANS; INFLAMMATION; RECURRENCE; RISK FACTORS;

EID: 33644814772     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089360     Document Type: Conference Paper

References (52)

1. Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Andersen CS, Stewart-Wynne EG: Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke 2000;31:2080-2086.
2. Hardie K, Hankey GJ, Jamrozik K, Broadhurst RJ, Anderson C: Ten-year risk of first recurrent stroke after a first-ever stroke in the Perth Community Stroke Study. Stroke 2004;35:731-735.
3. Elneihoum AM, Goransson M, Falke P, Janzon L: Three-year survival and recurrence after stroke in Malmö, Sweden: an analysis of stroke registry data. Stroke 1998;29:2114-2117.
4. Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C: Long-term risk of recurrent stroke after first-ever stroke. The Oxfordshire Community Stroke Project. Stroke 1994;25:333-337.
5. Hillen Th, Coshall C, Tilling K, Rudd AG, McGovern R, Wolfe CDA: Cause of stroke recurrence is multifactorial. Patterns, risk factors and outcomes of stroke recurrence in the South London Stroke Register. Stroke 2003;34:1457-1463.
6. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO: Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota 1975 through 1989. Neurology 1998;50:208-216.
7. Coull AJ, Rothwell PM: Underestimation of the early risk of recurrent stroke: evidence of the need for a standard definition. Stroke 2004;35:1925-1929.
8. Kang DW, Latour LL, Chalela JA, Dambrosia J, Warach S: Early ischemic lesion recurrence within a week after acute ischemic stroke. Ann Neurol 2003;54:66-74.
9. Coull AJ, Lovett JK, Rothwell PM: Oxford Vascular Study. Population-based study of early risk of stroke after transient ischemic attack or minor stroke: implications for public education and organization of services. Br Med J 2004;328:326.
10. Feinberg WM, Albers GW, Barnett HJ, Biller J, Caplan LR, Carter LP, Hart RG, Hobson RW, Kronmal RA, Moore WS, et al: Guidelines for the management of transient ischemic attacks. Circulation 1994;89:2950-2965.
11. Wolf PA, Clagett GP, Easton JD, Goldstein LB, Gorelick PB, Kelly-Hayes M, Sacco RL, Wishnant JP, et al: Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 1999;30:1991-1994.
12. European Stroke Initiative Executive Committee and Writing Committee: The European Stroke Initiative recommendations for stroke management update 2003. Cerebrovasc Dis 2003;16:311-337.
13. Egido JA, Alonso de Leciñana M, Martínez Vila E, Díez-Tejedor E; por el comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares: Guía para el tratamiento del infarto cerebral agudo. Neurología 2002;17(suppl 3):43-60.
14. Klijn CJM, Hankey GJ: Management of acute ischemic stroke: new guidelines from the American Stroke Association and European Stroke Initiative. Lancet Neurol 2003;2:698-701.
15. Sacco RL, Shi T, Zamanillo MC, Kargman DE: Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology 1994;44:626-634.
16. Leys D, Bandu L, Henon H, Lucas C, Mounier-Vehier F, Rondepierre P, Godefroy O: Clinical outcome in 287 consecutive young adults (15-45 years) with ischemic stroke. Neurology 2002;59:26-33.
17. Kappelle LJ, Adams, HP, Heffner ML, Torner JC, Gomez F, Biller J: Prognosis of young adults with ischemic stroke: a long-term follow-up study assessing recurrent vascular events and functional outcome in the Iowa Registry of Stroke in Young Adults. Stroke 1994;25:1360-1365.
18. Camerlingo M, Casto L, Censori B, Ferraro B, Caverni L, Manara O, Finazzi G, Radice E, Drago G, De Tommasi SM, Gotti E, Barbui T, Mamoli A: Recurrence after first cerebral infarction in young adults. Acta Neurol Scand 2000;102:87-93.
19. Marini C, Totaro R, Carolei A; for the National Research Council Study Group on Stroke in the Young: Long term prognosis of cerebral ischemia in young adults. National Research Council Study Group on Stroke in the Young. Stroke 1999;30:2320-2325.
20. Bailey RD, Hart RG, Benavente O, Pearce LA: Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology 2001;56:773-777.
21. Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, Stewart-Winne EG, et al: Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke 1998;29:2491-2500.
22. Petty GW, Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO: Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke 2000;31:1062-1068.
23. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C: Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521-1526.
24. Lovett JK, Coull AJ, Rothwell PM: Early risk of recurrence by subtype of ischemic stroke in population-based studies. Neurology 2004;62:569-573.
25. Kolominski-Rabas P, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU: Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence and long term survival in ischemic stroke subtypes: a population-based study. Stroke 2001;32:2735-2740.
26. Eliasziw M, Streifler JY, Fox AJ, Hachinski VC, Ferguson GG, Barnett HJ: Significance of plaque ulceration in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial. Stroke 1994;25:304-308.
27. Eliasziw M, Kennedy J, Hill MD, Buchan AM, Barnett HJM; for The North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group: Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. Can Med Assoc J 2004;170:1105-1109.
28. Molloy J, Markus HS: Asymptomatic embolization predicts stroke and TIA risk in patients with carotid artery stenosis. Stroke 1999;30:1440-1443.
29. Carra G, Visona A, Bonanome A, Lusiani L, Pesavento R, Bortolon M, Pagnan A: Carotid plaque morphology and cerebrovascular events. Int Angiol 2003;22:284-289.
30. Hennericci MG: The unstable plaque. Cerebrovasc Dis 2004;17(suppl 3):17-22.
31. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ, Carotid Endarterectomy Trialists Collaboration: Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004;363:915-924.
32. Wong KS, Li H: Long term mortality and recurrent stroke risk among Chinese stroke patients with predominant intracranial atherosclerosis. Stroke 2003;34:2361-2366.
33. European Atrial Fibrillation Trial Study Group: Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342:1255-1262.
34. Atrial Fibrillation Investigators: Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1,066 patients from three clinical trials. Arch Intern Med 1998;158:1316-1320.
35. Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography: Transesophageal echocardiographic correlates of thromboembolism in high risk patients with non-valvular atrial fibrillation. Ann Intern Med 1998;128:639-647.
36. Appelros P, Nydevik I, Viitanen M: Poor outcome after first-ever stroke. Predictors for death, dependency and recurrent stroke within the first year. Stroke 2003;34:122-126.
37. Rashid P, Leonardi-Bee J, Bath P: Blood pressure reduction and secondary prevention of stroke and other vascular event. Stroke 2003;34:2741-2748.
38. Friday G, Alter M, Lai S: Control of hypertension and stroke recurrence. Stroke 2002;33:2652-2657.
39. Rothwell PM, Howard SC, Spence JD, Carotid Endarterectomy Trialists' Collaboration: Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke 2003;34:2583-2590.
40. Colagiuri S, Cull CA, Holman RR, UKPDS Group: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? U.K. prospective diabetes study 61. Diabetes Care 2002;25:1410-1417.
41. Moroney JT, Bagiella E , Tatemichi TK, Paik MC, Stern Y, Desmond DW: Dementia after stroke increases the risk of long-term stroke recurrence. Neurology 1997;48:1317-1325.
42. Hénon H, Vroylandt P, Durieu I, Pasquier F, Leys D: Leukoaraiosis more than dementia is a predictor of stroke recurrence. Stroke 2003;34:2935-2940.
43. van Swieten JC, Kappelle LJ, Algra A, van Latum JC, Koudstaal PJ, van Gijn J: Hypodensity of the cerebral white matter in patients with transient ischemic attack or minor stroke: influence on the rate of subsequent stroke. Dutch TIA Trial Study Group. Ann Neurol 1992;32:177-183.
44. Di Napoli M, Papa F, Villa Pini Stroke Data Bank Investigators: Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients. Stroke 2002;33:1763-1771.
45. Arenillas JF, Alvarez-Sabin J, Molina CA, Chacon P, Montaner J, Rovira A, Ibarra B, Quintana M: C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 2003;34:2463-2468.
46. Di Napoli M: Editorial comment: C-reactive protein and vascular risk in stroke patients: potential use for the future. Stroke 2003;34:2468-2470.
47. Grau AJ, Boddy AW, Dukovic DA, Buggle F, Lichy C, Brandt T, Hacke W, CAPRIE Investigators: Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 2004;35:1147-1152.
48. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995;274:1049-1057.
49. Homocysteine Studies Collaboration: Homocysteine and risk of ischemic heart disease and stroke. JAMA 2002;288:2015-2022.
50. Del Ser T, Barba R, Herranz AS, Seijas V, López-Manglano C, Domingo J, Pondal M: Hyperhomocyst(e)inemia is a risk factor of secondary vascular events in stroke patients. Cerebrovasc Dis 2001;12:91-98.
51. Boysen G, Brander T, Christensen H, Truelsen T: Homocysteine and risk of recurrent stroke. Stroke 2003;34:1258-1261.
52. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M: Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004;291:565-575.